Penny stock at Rs 81.10 hit back-to-back 20% upper circuits
Thu, Apr 18, 2024 6:36 PM

Penny stock at Rs 81.10 hit back-to-back 20% upper circuits

A Flip by Shubhangi Gupta
Get it on Google Play
On Tuesday, shares of Fortis Malar Hospitals Ltd hit 20% upper circuit to Rs 81.10 per share from its previous closing of Rs 67.59. The shares of the company saw a spurt in volume by more than 5.06 times on BSE. The stock’s 52-week high is Rs 91.33 while its 52-week low is Rs 44. In the recent trading sessions, the stock has been hitting back-to-back upper circuits.

More great flips

Weekly Stock picks: ICICI Direct suggests these two shares to buy or sell

Weekly Stock picks: ICICI Direct suggests these two shares to buy or sell

Indian stock market: The Indian stock market indices, Sensex and the Nifty 50, ended Tuesday, April 30, trading session in negative, attributed to a late-session selloff influenced by weak global cues. The stock market remained closed on Wednesday, May 1 on account of Maharashtra Day.On Tuesday, Sensex concluded the session 189 points lower, representing a decrease of 0.25 percent.

Open Flip
S&P, Nasdaq open lower as investors take cover before Fed decision

S&P, Nasdaq open lower as investors take cover before Fed decision

The S&P 500 and Nasdaq opened lower on Wednesday as chip stocks led losses after downbeat results and markets exercised caution ahead of more economic data and the Federal Reserve's interest rate decision later in the day. The Dow Jones Industrial Average rose 29.6 points, or 0.08%, at the open to 37,845.56. The S&P 500 fell 6.7 points, or 0.13%, at the open to 5,029.03.

Open Flip
Johnson & Johnson seeks backing for $11 billion baby powder cancer drug

Johnson & Johnson seeks backing for $11 billion baby powder cancer drug

Johnson & Johnson will ask thousands of people suing over its allegedly tainted baby powder to vote for a settlement that would resolve all litigation for $11 billion — $2.1 billion more than the company offered last year.In a news release Wednesday, J&J urged those who blame the talc-based powder for ovarian cancer to support a third bankruptcy.

Open Flip

Join our Smart Investment Community

More than 1 Million users are using FlipItMoney to stay updated about the business and finance world! Join FlipItMoney now and take smart investment decisions!
Icon